D
Phathom Pharmaceuticals, Inc. PHAT
$4.41 $0.194.50%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue 81.41% 123.27%
Total Other Revenue -- --
Total Revenue 81.41% 123.27%
Cost of Revenue 61.93% 71.22%
Gross Profit 84.69% 135.31%
SG&A Expenses 0.77% 0.30%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 2.22% 2.98%
Operating Income 16.07% 8.41%
Income Before Tax 13.00% 6.42%
Income Tax Expenses -- --
Earnings from Continuing Operations 13.00% 6.42%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 13.00% 6.42%
EBIT 16.07% 8.41%
EBITDA 16.12% 8.43%
EPS Basic 20.87% 15.20%
Normalized Basic EPS 20.86% 15.20%
EPS Diluted 20.87% 15.20%
Normalized Diluted EPS 20.86% 15.20%
Average Basic Shares Outstanding 9.93% 10.37%
Average Diluted Shares Outstanding 9.93% 10.37%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings